Drugs / NBP607-TIV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03020628 Comparator | Oct 2016 → Mar 2017 | influenza | SK Chemicals Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NBP607-TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03020628 ↗ |
| Modality | Vaccine | “Trivalent Inactivated Cell Culture-derived Influenza Vaccine” NCT03020628 ↗ |
| Route | Intramuscular | “Intra-muscular” NCT03020628 ↗ |